RxDoctor Payments Data

Hollie Frazier

Family · Mc Kenzie, TNNPI 1013544576

Payments from drug & device makers

$602in general payments, 2019–2025

Across 31 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$82
  • GSK$69
  • Dexcom, Inc.$60
  • Exact Sciences$49
  • Lilly USA, LLC$48
  • Amgen$43
  • plus $250 from 10 others

What the payments were for

  • Food & beverage$602100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$602 in reported general payments places this provider in the 55th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$8,422
Medicare patients
82
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide178$187,875
FarxigaDapagliflozin Propanediol81$100,800
JardianceEmpagliflozin129$94,721
EliquisApixaban102$79,738
JanuviaSitagliptin Phosphate78$75,221
Trelegy ElliptaFluticasone/Umeclidin/Vilanter111$68,234
MounjaroTirzepatide50$55,837
TrulicityDulaglutide35$45,001
Breztri AerosphereBudesonide/Glycopyr/Formoterol51$33,088
VraylarCariprazine Hcl20$27,246
LinzessLinaclotide40$23,818
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen996$23,567
XareltoRivaroxaban23$23,499
CaplytaLumateperone Tosylate11$21,277
RexultiBrexpiprazole14$20,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$40$187,875178 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$82$145,780157 claims
Lilly USA, LLCMounjaro, Trulicity$48$100,83885 claims
Boehringer IngelheimJardiance$30$94,721129 claims
PfizerEliquis$37$79,738102 claims
GSKTrelegy Ellipta, Breo Ellipta$69$76,175132 claims
AbbVieVraylar, Linzess$22$51,06460 claims
Otsuka America Pharmaceutical, Inc.Rexulti$16$20,20114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,706 family providers in Tennessee.

Other family in Mc Kenzie

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →